What people pay for Wegovy® in the U.S. ranges from a $25 monthly copay (commercial coverage plus the manufacturer savings offer) to several hundred dollars a month self-pay, depending on insurance status and which savings program they use. The monthly list price commonly cited is largely a theoretical number. Few patients actually pay it.
Here is the short version of what matters:
- Commercially insured patients who qualify for the Wegovy Savings Offer from Novo Nordisk can pay as little as $25/month out of pocket.
- Self-pay patients using NovoCare Pharmacy (Novo Nordisk’s direct program) pay roughly $149 to $399 a month depending on formulation and dose (see the table below).
- Medicare Part D beneficiaries may qualify for the Medicare GLP-1 Bridge program, a temporary program with a fixed monthly copay; confirm current terms at Medicare.gov.
- If you have no insurance and no access to NovoCare, retail cash prices through coupon sites like GoodRx often run higher than the manufacturer’s own direct channel.
The single fastest move: if you have commercial insurance, apply for the Wegovy Savings Offer before your first fill. If you’re uninsured, check NovoCare self-pay pricing first, especially for oral starter doses, which tend to be the lowest entry point.
Table of Contents
- How much does Wegovy actually cost? A full price breakdown
- How does insurance change what you pay for Wegovy?
- How to lower your Wegovy cost: the best savings options ranked
- How to find your exact out-of-pocket price in 15 minutes
- What recent data says about coverage and upcoming price changes
- Key Takeaways
- The real cost question nobody asks first
- A clearer path to GLP-1 treatment without the insurance maze
- Useful sources for verifying Wegovy prices and coverage
- FAQ
How much does Wegovy actually cost? A full price breakdown
As of July 2026, the official Wholesale Acquisition Cost (WAC) for a 28-day supply of Wegovy is approximately $1,349, but few patients actually pay this list price. That is the sticker price, the number that flows through the supply chain before rebates, insurance negotiations, or manufacturer programs touch it. Think of it the way you think of a car’s MSRP: it sets the ceiling, but almost nobody pays it.
What people actually pay depends on three things: their insurance situation, which formulation and dose they are on, and which savings channel they use.
Wegovy formulations and realistic self-pay prices
Wegovy comes in two delivery formats: an injectable pen (the original subcutaneous injection, administered once weekly) and an oral pill (a newer option). Each has different dose strengths that correspond to different price points through NovoCare’s self-pay program.
| Formulation / Dose | List Price (WAC) | NovoCare Self-Pay Price |
|---|---|---|
| Oral starter dose | $1,349/month | $149/month |
| Oral maintenance dose | $1,349/month | Pricing not publicly listed separately |
| Injectable starter (intro offer) | $1,349/month | $199 for first fill |
| Injectable maintenance | $1,349/month | $349/month |
| Wegovy HD pen (higher dose) | $1,349/month | $399/month |
One “month” of Wegovy means one box of four injectable pens (a four-week supply) or one bottle of 30 oral tablets. Dose strength determines which pack you receive, and the pack price scales accordingly through NovoCare.
The introductory $199 injectable rate applies to first fills only, with eligibility and expiration terms that change. Always confirm current terms directly with NovoCare before assuming the intro price applies to your situation.
Pro Tip: When a manufacturer runs its own self-pay pharmacy channel, it is often cheaper than what GoodRx or other coupon marketplaces show for the same drug. Verify program eligibility and expiration dates for any intro offer before you fill, because these promotions have limited windows.
A few things worth knowing about the oral option: the starter dose at $149/month through NovoCare is the lowest cash-pay entry point currently available for Wegovy. For patients who want to try the medication before committing to the injectable maintenance cost, starting with the oral formulation through NovoCare can be a practical way to assess tolerability at a lower monthly spend.
How does insurance change what you pay for Wegovy?
Coverage changes the math significantly, but it does not automatically make Wegovy affordable. Those are two different things, and conflating them is one of the most common mistakes people make when budgeting for this medication.
Coverage rates and prior authorization
Coverage of Wegovy for weight management varies widely among commercial health plans, and many insured patients will find it excluded from their formulary entirely. For those whose plans do cover it, prior authorization is usually required. Insurers typically ask for:
- A BMI of 30 or higher, or a BMI of 27 or higher with at least one weight-related condition (such as type 2 diabetes, hypertension, or sleep apnea)
- Documentation of prior weight-loss attempts, usually including a structured lifestyle intervention
- A prescriber’s clinical notes supporting medical necessity
Prior authorization takes time, often 1–3 weeks, and a denial means you either appeal or pay out of pocket while the process plays out. That delay affects your immediate cost and your start date.
What “covered” actually costs you
Coverage and affordability are not the same thing. A patient with commercial insurance and the Wegovy Savings Offer active may pay $25/month. That same patient, in the deductible phase of a high-deductible health plan (HDHP), could pay the plan’s full negotiated rate, which can be several hundred dollars a month, until the annual deductible is satisfied.
Here is how those two scenarios play out in practice:
Scenario A: Copay plan with Savings Offer active. A patient on a standard commercial plan where Wegovy is covered at a fixed copay, say $150/month, applies for the Wegovy Savings Offer. The manufacturer’s card covers the gap, bringing the patient’s out-of-pocket cost down to $25/month. This is the best-case insured scenario.
Scenario B: High-deductible plan, deductible not yet met. A patient on an HDHP with a $3,000 annual deductible fills Wegovy in January. Their insurer’s negotiated rate is $800/month. They pay $800/month until the deductible clears, then shift to coinsurance (often 20–30% of the negotiated rate). The Savings Offer may not apply here in the same way, and self-pay through NovoCare would not count toward the deductible unless the insurer permits manual reimbursement.
The Wegovy Savings Offer lowers what you pay at the pharmacy counter when your plan covers the drug. It does not create coverage where none exists, and it does not help government beneficiaries (Medicare, Medicaid, VA, TRICARE) who are excluded from manufacturer savings cards.
How to lower your Wegovy cost: the best savings options ranked
Not all savings routes are equal. Here is how they stack up by typical out-of-pocket impact, from most to least effective for most patients.
-
Wegovy Savings Offer (commercially insured patients). For eligible patients with commercial insurance, this manufacturer card can bring the monthly copay down to $25/month. Apply directly through Wegovy.com or NovoCare before your first fill. Government beneficiaries (Medicare, Medicaid, VA, TRICARE) are not eligible.
-
NovoCare self-pay program (uninsured or ineligible for savings card). Oral starter doses run approximately $149/month; injectable maintenance runs approximately $349/month; the HD pen runs approximately $399/month through NovoCare. This is the most predictable cash-pay option and generally beats retail coupon prices for Wegovy. Enroll at NovoCare.com and confirm current eligibility terms.
-
Medicare GLP-1 Bridge program (Medicare Part D beneficiaries). This temporary federal program offers a fixed monthly copay for eligible Part D beneficiaries. See the next section, and confirm current terms at Medicare.gov.
-
Retail pharmacy pricing with coupon sites (GoodRx and similar). These can help for some drugs, but for Wegovy specifically, GoodRx-style prices often come in higher than NovoCare’s direct program. Check both before filling. Also note: cash purchases through coupon sites typically do not count toward your insurance deductible, so if you are mid-deductible, paying cash may cost you twice.
How to enroll in the Wegovy Savings Offer
- Go to Wegovy.com and navigate to the savings/cost page.
- Confirm you have commercial insurance (not Medicare, Medicaid, or a government plan).
- Complete the online enrollment form and receive your savings card or activation code.
- Present the card at your pharmacy when filling the prescription.
- Confirm the final copay with the pharmacist before leaving.
A note on NovoCare vs. retail pharmacies
NovoCare ships directly to your home, which removes the retail pharmacy markup. Costco Pharmacy is worth checking as a retail alternative, since it tends to have lower dispensing fees than chain pharmacies, but for Wegovy specifically, NovoCare’s self-pay pricing is often the better starting point for uninsured patients.
Pro Tip: Before paying cash anywhere, call NovoCare and ask for the current self-pay price for your specific dose and formulation. Prices and promotional offers change, and the rep can confirm whether you qualify for any current intro pricing.
How to find your exact out-of-pocket price in 15 minutes
Knowing the general ranges is useful. Knowing your specific number is what you actually need before calling in a prescription.
-
Check your plan’s formulary. Log into your insurer’s member portal and search for “semaglutide” or “Wegovy.” Look for the tier it sits on (Tier 3, Tier 4, or specialty) and whether prior authorization is required.
-
Call your insurer and ask two specific questions. First: “Is Wegovy covered under my plan for weight management, and what tier is it?” Second: “Am I currently in my deductible phase, and if so, what is the negotiated rate for this drug?”
-
Apply for the Wegovy Savings Offer. Do this before your first fill, not after. Go to Wegovy.com, confirm commercial insurance eligibility, and enroll. Then call your pharmacy with the savings card information and ask them to run a test claim to confirm your actual copay.
-
Price the prescription at NovoCare and at a local retail pharmacy. Get the NovoCare self-pay quote for your dose. Then check Costco Pharmacy or your preferred retail chain. Compare the two numbers against your insured copay (with and without the Savings Offer active).
-
Ask your provider to submit prior authorization if required. Request that they document prior weight-loss attempts and your BMI in the PA submission. Ask how long the process typically takes with your insurer, and whether the office has a PA coordinator who handles these submissions regularly.
Pro Tip: When you call your insurer or pharmacist, use this script: “I have a prescription for semaglutide (Wegovy) for weight management. Can you tell me the current negotiated rate, whether prior authorization is required, and whether I’m currently in my deductible phase?” Save the rep’s name, the date, and the reference number for that call.
What recent data says about coverage and upcoming price changes
The coverage picture for Wegovy is improving, but slowly. Many commercial plans still do not cover the drug for weight management, and even among those that do, prior authorization requirements create a meaningful access barrier for many patients.
The most important pricing development on the horizon: Novo Nordisk has announced a planned list-price reduction for Wegovy to approximately $675/month, effective January 1, 2027. That is roughly a 50% cut from the current $1,349 WAC.
Who benefits most from a list-price cut? Patients on high-deductible plans and those paying coinsurance, since their cost is a percentage of the drug’s cost rather than a flat copay. Reducing the list price proportionally lowers their share. Patients on flat-copay plans will see less direct impact, since their copay is set by the plan, not the list price.
For patients currently budgeting for Wegovy, the 2027 reduction is worth knowing about but should not delay treatment decisions. A year of waiting to save on cost has its own tradeoffs, particularly for patients whose weight-related conditions are progressing.
Medicare GLP-1 Bridge program: what you need to know
The Medicare GLP-1 Bridge is a temporary federal program that gives eligible Medicare Part D beneficiaries a fixed monthly copay for covered GLP-1 medications. Program dates, eligibility rules, and how the copay counts toward Part D cost-sharing limits are set by the Centers for Medicare & Medicaid Services (CMS) and may change. Confirm your eligibility and current program terms on Medicare.gov before assuming you qualify.
Key Takeaways
Wegovy’s list price is rarely what patients pay; commercially insured patients with the Savings Offer active can pay as little as $25/month, while self-pay patients using NovoCare pay roughly $149 to $399 a month depending on formulation and dose.
| Point | Details |
|---|---|
| List price vs. real cost | The list price is a ceiling; most patients pay lower monthly amounts through savings programs or NovoCare self-pay. |
| Insurance ≠ affordability | High-deductible plan patients may pay substantial out-of-pocket costs until their deductible clears, even with coverage. |
| Savings Offer priority | Apply for the Wegovy Savings Offer before your first fill; it can cap commercially insured costs at $25/month. |
| 2027 list-price cut | Novo Nordisk plans to reduce Wegovy’s list price starting January 1, 2027, benefiting coinsurance and HDHP patients most. |
| Compounded alternative | Archie Health does not sell Wegovy®. It offers compounded semaglutide and compounded tirzepatide (not FDA-approved) in a cash-pay plan that includes telehealth assessment, coaching, and medication if prescribed. |
The real cost question nobody asks first
Most people researching Wegovy cost start with the list price and work backward. That is the wrong direction. The number that matters is what you will pay at the pharmacy counter on month one, and then what you will pay on month six, after your deductible resets or your savings card eligibility changes.
The conventional wisdom says: “Get insurance to cover it and use the savings card.” That advice is correct as far as it goes, but it skips the part where a patient on a high-deductible plan pays $800/month for the first few months of the year while the deductible clears. For someone earning a median household income, that is not a minor inconvenience. It is a treatment-stopping number.
One thing that often gets underestimated is the value of predictability. The NovoCare self-pay program, for all its limitations, gives you a known monthly number that does not change based on your deductible phase or your insurer’s formulary decisions. For some patients, especially those who have already been through the prior-authorization process once and lost, that predictability is worth more than the theoretical savings of going through insurance.
The guiding question to ask your prescriber and insurer before starting: “What will I pay on month one, and what will I pay after my deductible resets in January?” Those two numbers, not the list price, are what your budget actually needs.
And before changing formulations, switching pharmacies, or filling outside your plan, consult your prescriber. The clinical and financial decisions here are connected, and the right path depends on your specific health situation, not just the price comparison.
This article is for general informational purposes only and does not constitute medical or financial advice. Confirm current pricing, eligibility, and coverage details with your insurer, pharmacist, or a qualified healthcare provider.
A clearer path to GLP-1 treatment without the insurance maze
If the prior-authorization process, deductible math, and savings-card eligibility rules described above sound like a lot to manage, that is because they are. Archie Health offers a cash-pay alternative with a predictable monthly price, but it is a different product: Archie Health does not sell Wegovy®. Through Archie Health, independent licensed clinicians may prescribe compounded semaglutide or compounded tirzepatide, which are not FDA-approved and are not Wegovy®, Ozempic®, Zepbound®, or Mounjaro®. Archie Health does not sell brand-name medications.
The process works like this: you complete an online intake, an independent licensed provider reviews your case and prescribes compounded semaglutide or compounded tirzepatide only if appropriate, and the pharmacy ships your medication to you. Clinician review and coaching are included in your plan price.
Compounded semaglutide costs $159 for the first month, then $299/mo. Compounded tirzepatide costs $249 for the first month, then $399/mo. Plans renew automatically until you cancel. The price includes clinician review, coaching, medication if prescribed, and shipping, and it is the same at every dose. Archie Health does not bill insurance, and all costs are shown before checkout.
If you are ready to see whether you qualify, start your intake at Archie Health or review the GLP-1 pricing and FAQ page for a full breakdown of how the program works.
Useful sources for verifying Wegovy prices and coverage
Prices and program terms change. Before filling a prescription or enrolling in a savings program, verify current information directly from these sources:
- Wegovy.com (cost and savings pages): Current Savings Offer terms, Medicare GLP-1 Bridge details, and eligibility rules for the $25 copay program.
- NovoCare: Self-pay pricing by formulation and dose, home delivery enrollment, and introductory offer terms.
- Medicare.gov weight-loss drug coverage page: Medicare GLP-1 Bridge program eligibility, Part D coverage rules, and prior-authorization criteria.
- Your insurer’s member portal or benefits line: Check formulary tier, prior-authorization requirements, and your current deductible balance before filling.
- Costco Pharmacy: Worth checking as a retail alternative for cash-pay pricing; call the pharmacy directly for a current quote on your specific dose.
- Archie Health FAQ and pricing page: Explains Archie Health’s compounded semaglutide and compounded tirzepatide plans, which are not Wegovy®, plus what is included in the plan price, and how billing works.
When you enroll in any savings program, capture the confirmation number, the enrollment date, and the stated price. Program terms can change mid-year, and having documentation protects you if a pharmacy claim is rejected.
FAQ
Where is the cheapest price for Wegovy?
The lowest available price for most patients is through NovoCare’s self-pay program, where oral starter doses run approximately $149/month. Commercially insured patients who qualify for the Wegovy Savings Offer can pay as little as $25/month if they meet program eligibility requirements.
How are people getting Wegovy for $25 a month?
The $25 copay comes from combining commercial insurance coverage with the Wegovy Savings Offer, a manufacturer program from Novo Nordisk. Government beneficiaries (Medicare, Medicaid, VA, TRICARE) are not eligible for this offer.
What does Wegovy cost at Costco?
Costco Pharmacy tends to have lower dispensing fees than chain pharmacies, but Wegovy’s cash price there still reflects the drug’s high list price. For most uninsured patients, NovoCare’s self-pay program will come in lower than any retail pharmacy, including Costco. Call Costco’s pharmacy directly for a current quote on your specific dose.
Is Wegovy cheaper than Ozempic?
Both drugs contain semaglutide, but they are FDA-approved for different indications and carry similar list prices. Ozempic is approved for type 2 diabetes management, which means more commercial plans cover it and at lower tiers. Wegovy, approved for weight management, faces more coverage restrictions, making out-of-pocket costs higher for many patients despite the similar WAC.
Will Wegovy get cheaper in 2027?
Novo Nordisk has announced a planned list-price reduction for Wegovy to approximately $675/month, effective January 1, 2027. Patients on high-deductible plans or paying coinsurance will see the most direct benefit, since their costs are calculated as a percentage of the list price.